<DOC>
	<DOCNO>NCT00701155</DOCNO>
	<brief_summary>This study conduct Africa . The aim observational study evaluate incidence serious adverse drug reaction use insulin Levemir® normal clinical practice condition Egypt .</brief_summary>
	<brief_title>Observational Study Evaluate Safety While Using Levemir®</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>After physician decision make use insulin detemir , subject Type 1 Type 2 diabetes mellitus eligible study , include newlydiagnosed subject never receive insulin insulin analogue . The selection subject discretion individual physician . Subjects unlikely comply protocol , e.g. , uncooperative attitude , inability return final visit ; Subjects currently treat insulin detemir ; Subjects previously enrol study Subjects hypersensitivity insulin detemir excipients Pregnancy , breastfeeding , intention become pregnant judge use adequate contraceptive measure . ( Adequate contraceptive measure intrauterine device , oral contraceptive barrier method )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>